NovoCure Limited

NVCR· NASDAQ· Health Care· Health Care Equipment & Services

$13.14+0.23%

2026-10-30

Financials

Valuation Metrics

NovoCure Limited's Market Cap is $1.52B. At end of 2025 it was $1.44B. Ranked #2096 of 3,114 in US market (top 67%), #809 of 1,472 on NASDAQ (top 55%), #132 of 203 in Health Care Equipment & Services (top 65%) by Market Cap.

Investment Metrics(as of 2026-10-30)

Metric	Value	Rank
Size
Market Cap	$1.52B	US#2,096/3,114 Sec#132/203
Revenue	$699M	US#2,084/3,114 Sec#130/203
Net Income	$-149M	US—/3,114 Sec—/203
Total Assets	$795M	US#2,567/3,114 Sec#137/203
Net Assets	$338M	US#2,460/3,114 Sec#139/203
Value
P/B	4.50x	US#2,229/3,114 Sec#134/203
P/S	2.18x	US#1,473/3,114 Sec#102/203
FCF Yield	-1.39%	US—/3,114 Sec—/203
Profitability
ROE	-43.94%	US#2,648/3,114 Sec#167/203
ROA	-18.68%	US#2,775/3,114 Sec#174/203
Op. Margin	-22.08%	US#2,589/3,114 Sec#167/203
Revenue Growth	10.95%	US#1,168/3,114 Sec#82/203
Financial Health
Debt Ratio	135.20%	US#1,382/3,114 Sec#127/203
Total Debt	$233M	US#2,193/3,114 Sec#120/203
FCF	$-21M	US#2,428/3,114 Sec#160/203
Cash	$94M	US#2,270/3,114 Sec#142/203
Current Ratio	2.89x	US#821/3,114 Sec#81/203
Performance
1Y Return	2.50%	US#1,459/3,114 Sec#112/203
1M Return	-17.62%	US#2,346/3,114 Sec#175/203
From 52W High	-38.74%	US#2,025/3,114 Sec#154/203
1Y MDD	-34.42%	US#1,479/3,114 Sec#80/203
Trading
Volume	1,621,254 shares	US#1,149/3,114 Sec#62/203
Trading Value	$21M	US#1,833/3,114 Sec#128/203
Per Share
EPS	$-1.28	US—/3,114 Sec—/203
BPS	$2.92	US#2,495/3,114 Sec#164/203